Generalized pustular psoriasis may be caused or triggered by various factors, including genetic mutations, infections, and certain medications. Generalized pustular psoriasis (GPP) is a severe ...

Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed, according to a study recently published online in ...

Stress, infections, and corticosteroid withdrawal are known triggers of generalized pustular psoriasis (GPP). However, doctors cannot attribute every GPP flare to a specific cause. Psoriasis is an ...

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a diverse range of therapeutic alternatives for treatment ...

Patients with generalized pustular psoriasis continued to experience frequent flares that were often uncontrolled by ...

Vanda's strong financials and product lineup show promise, but management concerns and FDA disputes may hinder growth. Learn ...

This case of drug-induced AGEP in pregnancy, the first described to the best of our knowledge, demonstrates the complex immune interplay between cytokines and effector cells in this pustular acute ...

These findings suggest potential benefits of continuous subcutaneous spesolimab treatment for generalized pustular psoriasis (GPP). Boehringer Ingelheim announced new analyses to be presented at the ...

German pharmaceutical giant Boehringer Ingelheim said China remains a market of continued interest and would keep up the ...

GENERALISED pustular psoriasis (GPP) is a severe, systemic inflammatory disease distinct from plaque psoriasis. It is characterised by unpredictable flares of sterile pustules, often accompanied by ...

The company’s pipeline products also include Imsidolimab, an IL-36R antagonist, for the treatment of generalized pustular psoriasis; VTR-297, a small molecule histone deacetylase inhibitor to ...